Balentine LLC’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-102	Closed	-$11K	–	930
2020 Q2	$11K	Buy	102 +29	+40%	+$3.08K	﹤0.01%	546
2020 Q1	$7K	Sell	73 -285	-80%	-$28K	﹤0.01%	441
2019 Q4	$39K	Buy	358 +327	+1,055%	+$35K	﹤0.01%	226
2019 Q3	$3K	Buy	31 +24	+343%	+$2.71K	﹤0.01%	626
2019 Q2	$1K	Buy	+7	New	+$902	﹤0.01%	752
2018 Q3	–	Sell	-70	Closed	-$9K	–	394
2018 Q2	$9K	Buy	+70	New	+$8.18K	﹤0.01%	104
2018 Q1	–	Sell	-170	Closed	-$20K	–	573
2017 Q4	$20K	Sell	170 -3	-2%	-$365	﹤0.01%	383
2017 Q3	$24K	Sell	173 -48	-22%	-$6.52K	﹤0.01%	370
2017 Q2	$27K	Buy	221 +90	+69%	+$10.5K	﹤0.01%	332
2017 Q1	$16K	Hold	131	–	–	﹤0.01%	379
2016 Q4	$16K	Sell	131 -36	-22%	-$4.41K	﹤0.01%	356
2016 Q3	$20K	Buy	167 +36	+27%	+$4.63K	﹤0.01%	280
2016 Q2	$15K	Buy	+131	New	+$18.6K	﹤0.01%	285